SFS
QNCX icon

Sowell Financial Services’s Quince Therapeutics QNCX Stock Holding History

Sowell Financial Services’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$5K – 2189
2021
Q1 		$5K Hold
1
– – ﹤0.01% 2613
2020
Q4 		$5K Buy
+1
New +$8.86K ﹤0.01% 2291
2020
Q3 		– Hold
0
– – – 2411

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $3.16B AUM 42.38% 1-Year Est. Return

Sowell Financial Services's QNCX Position: Q2 2021 in Review

Sowell Financial Services sold out of Quince Therapeutics (QNCX) in Q2 2021, closing a stake of 1 share — an estimated $5K sold.

Sowell Financial Services first reported a position in QNCX in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 100 funds tracked by Wall St. Rank hold QNCX as of Q2 2021.

  • Sowell Financial Services reported no remaining Quince Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1 Quince Therapeutics share in Q2 2021, an estimated $5K.
  • Sowell Financial Services first reported a position in Quince Therapeutics in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Quince Therapeutics position peaked at $5K in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.